Search results for "Immune complex"

showing 10 items of 14 documents

Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.

1998

SUMMARYComplement receptor type 1 (CR1) is an integral membrane protein of many haematopoietic cells and plays an important role in the clearance of complement-associated immune complexes, favouring their transport to liver and spleen macrophages. A small amount of soluble CR1 (sCR1) is also found in plasma and might originate directly from release of leucocytes and other circulating cells. In previous studies, an increase in serum sCR1 level has been observed in liver cirrhosis and end-stage renal failure. High levels have also been found in patients with some haematologic malignancies. sCR1 serum levels were measured using a specific double sandwich ELISA assay. The present study demonstr…

Liver Cirrhosismedicine.medical_specialtyCirrhosisCarcinoma HepatocellularImmunologyChronic liver diseaseLiver diseaseImmune systemInternal medicinemedicineImmunology and AllergyHumansmedicine.diagnostic_testbusiness.industryLiver Diseasesmedicine.diseaseHepatitis CImmune complexReceptors ComplementEndocrinologyHepatocellular carcinomaImmunologyChronic DiseaseOriginal ArticleLiver functionLiver function testsbusinessClinical and experimental immunology
researchProduct

Affinity Sensors for the Diagnosis of COVID-19

2021

The coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was proclaimed a global pandemic in March 2020. Reducing the dissemination rate, in particular by tracking the infected people and their contacts, is the main instrument against infection spreading. Therefore, the creation and implementation of fast, reliable and responsive methods suitable for the diagnosis of COVID-19 are required. These needs can be fulfilled using affinity sensors, which differ in applied detection methods and markers that are generating analytical signals. Recently, nucleic acid hybridization, antigen-antibody interaction, and change of reactive oxyge…

AnalyteCoronavirus disease 2019 (COVID-19)Computer scienceimmune complexSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:Mechanical engineering and machinerySARS-CoV-2 virus02 engineering and technologyReviewelectrochemical immunosensors03 medical and health sciencesCOVID-19 ; SARS-CoV-2 virus ; RNA analysis ; bioelectrochemistry ; biosensors ; electro- chemical immunosensors ; antigen-antibody interaction ; immune complex ; molecularly imprinted polymers (MIPs) ; surface modification by immobilization of biomoleculesElectrochemical biosensorDetection theorylcsh:TJ1-1570Electrical and Electronic EngineeringSurface plasmon resonance030304 developmental biologysurface modification by immobilization of biomolecule0303 health sciencesMechanical EngineeringbioelectrochemistryCOVID-19surface modification by immobilization of biomoleculesRNA analysis021001 nanoscience & nanotechnologybiosensorsAntigen-antibody interactionControl and Systems Engineeringmolecularly imprinted polymers (MIPs)antigen-antibody interaction0210 nano-technologyBiological systemBiosensorMicromachines
researchProduct

Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.

1990

The pattern of free and antibody-complexed HIV antigen and the antibody profile were investigated retrospectively in 305 serum samples taken from 22 AIDS patients before and during the development of AIDS and from 40 apparently healthy seropositive individuals. Most AIDS patients were found positive for both free and complexed antigen and had high gp41 antibody titres but low or undetectable p24 antibody. Four different patterns of HIV antigenaemia were observed: 1) positive for both free and complexed antigen; 2) negative for free HIV antigen at first, but always positive for complexed antigen; 3) positive for free antigen without complexed antigen; and 4) negative for both free and comple…

AdultMaleAntigen-Antibody ComplexHIV AntigensHIV Core Protein p24Gene Products gagAntigen-Antibody ComplexBiologyHIV AntibodiesVirusImmune systemAcquired immunodeficiency syndrome (AIDS)AntigenHIV SeroprevalenceVirologyHIV SeropositivitymedicineHumansSubstance Abuse IntravenousAcquired Immunodeficiency SyndromeViral Core Proteinsmedicine.diseaseVirologyImmune complexHIV Envelope Protein gp41Infectious DiseasesItalyImmunologybiology.proteinFemaleViral diseaseAntibodyBiomarkersJournal of medical virology
researchProduct

Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.

1988

We investigated the connection between the C1q solid-phase binding assay (C1q SPBA) and double-stranded DNA antibodies, and analyzed the immune complex material in systemic lupus erythematosus (SLE) sera. Comparison with a new monoclonal assay for C1q-bearing immune complexes (the 242G3 assay) revealed that the immune complexes in SLE bind specifically to solid-phase C1q, and not to fluid-phase C1q. The C1q solid-phase binding activity sedimented as 7S IgG, was insensitive to DNase treatment, and could be selectively absorbed by C1q-coupled beads and by bovine serum albumin-anti-bovine serum albumin C1q beads, but not by DNA. Thus, antibodies to double-stranded DNA do not interfere in the C…

Complement Activating EnzymesImmunologySerum albuminchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayAntigen-Antibody Complexurologic and male genital diseasesfluids and secretionsImmune systemRheumatologyimmune system diseasesComplement C1medicineImmunology and AllergyHumansLupus Erythematosus SystemicPharmacology (medical)Bovine serum albuminskin and connective tissue diseasesAutoantibodiesLupus erythematosusbiologybusiness.industryLigand binding assayComplement C1qAutoantibodyDNA Neoplasmmedicine.diseaseImmune complexImmunoglobulin GImmunologybiology.proteinCollagenAntibodybusinessUltracentrifugationArthritis and rheumatism
researchProduct

Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: Cellular immune reactions and response to interferon trea…

1994

The case of a young female patient with chronic active hepatitis B, vasculitic purpura, edema, and circulating immune complexes due to mixed Cryoglobulinemia is described. Serum transami-nases were elevated. Serological assays showed hepatitis B surface antigen (HBsAg), antibody to hepatitis B e antigen (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc) antibodies but no antibody to hepatitis C virus (anti-HCV) or antibody to hepatitis delta virus (anti-HDV) antibodies. Using hepatitis B virus-polymerase chain reaction (HBV-PCR) and direct sequencing a precore/core (preC/C) mutant unable to synthesize HBeAg was detected in serum. HBV antigens were demonstrated in the circulatin…

Hepatitis B virusHBsAgAdolescentT-Lymphocytesmedicine.disease_causeAntigenVirologymedicineHumansHepatitis B e AntigensHepatitis ChronicHepatitis B virusImmunity Cellularbiologybusiness.industryInterferon-alphavirus diseasesHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseasesHBcAgInfectious DiseasesCryoglobulinemiaHBeAgHepadnaviridaeMutationImmunologyLeukocytes MononuclearFemalebusinessImmune complex diseaseFollow-Up StudiesJournal of Medical Virology
researchProduct

Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitus

1984

Platelets from diabetic subjects with circulating immune complexes (CIC) synthesized greater amounts of thromboxane than did platelets from CIC-negative patients or controls. In view of the known action of CIC on platelet function, a relationship between these two factors may be suggested in the initiation and progression of microangiopathy in diabetes.

Blood PlateletsMalemedicine.medical_specialtyThromboxaneInsulin AntibodiesEndocrinology Diabetes and MetabolismAntigen-Antibody ComplexPathogenesisImmune systemInternal medicineDiabetes mellitusmedicineInternal MedicineHumansPlateletIn patientChildbusiness.industryMicroangiopathyThromboxanesComplement C3medicine.diseaseImmune complexAntibodies Anti-IdiotypicThromboxane B2Diabetes Mellitus Type 1EndocrinologyImmunoglobulin GImmunologyFemalebusinessDiabetes
researchProduct

Biosensors for the determination of SARS-CoV-2 virus and diagnosis of COVID-19 infection

2022

Monitoring and tracking infection is required in order to reduce the spread of the coronavirus disease 2019 (COVID-19), induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To achieve this goal, the development and deployment of quick, accurate, and sensitive diagnostic methods are necessary. The determination of the SARS-CoV-2 virus is performed by biosensing devices, which vary according to detection methods and the biomarkers which are inducing/providing an analytical signal. RNA hybridisation, antigen-antibody affinity interaction, and a variety of other biological reactions are commonly used to generate analytical signals that can be precisely detected using electro…

QH301-705.5immune complexSARS-CoV-2 virusBiosensing TechniquesReviewCatalysisInorganic Chemistryelectrochemical immunosensorsCOVID-19 TestingHumansSerologic TestsPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999SpectroscopySARS-CoV-2bioelectrochemistryOrganic ChemistryCOVID-19General MedicineRNA analysisbiosensorsimmobilisation of biomoleculesNanostructuresComputer Science ApplicationsChemistryMolecular Diagnostic Techniquesmolecularly imprinted polymers (MIPs)antigen-antibody interactionCOVID-19 ; SARS-CoV-2 virus ; biosensors ; electrochemical immunosensors ; bioelectrochemistry ; RNA analysis ; antigen-antibody interaction ; immune complex ; immobilisation of biomolecules ; molecularly imprinted polymers (MIPs)
researchProduct

T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita

2016

AbstractT cells are key players in autoimmune diseases by supporting the production of autoantibodies. However, their contribution to the effector phase of antibody-mediated autoimmune dermatoses, i.e., tissue injury and inflammation of the skin, has not been investigated. In this paper, we demonstrate that T cells amplify the development of autoantibody-induced tissue injury in a prototypical, organ-specific autoimmune disease, namely epidermolysis bullosa acquisita (EBA) – characterized and caused by autoantibodies targeting type VII collagen. Specifically, we show that immune complex (IC)-induced inflammation depends on the presence of T cells – a process facilitated by T cell receptor (…

0301 basic medicineEpidermolysis bullosa acquisitamedicine.medical_specialtyCollagen Type VIINeutrophilsT-LymphocytesGene ExpressionMice NudeInflammationAntigen-Antibody ComplexCell CommunicationEpidermolysis Bullosa AcquisitaArticleMice03 medical and health sciencesCricetulus0302 clinical medicinemedicineAnimalsHumansAutoantibodiesSkinAutoimmune diseaseMice Inbred BALB CMultidisciplinarybusiness.industryT-cell receptorAutoantibodyAntibodies MonoclonalReceptors Antigen T-Cell gamma-deltamedicine.diseaseNatural killer T cellDermatologyImmune complexMice Inbred C57BLDisease Models Animal030104 developmental biologyLymphatic systemImmunoglobulin GImmunologyNatural Killer T-CellsLymph NodesRabbitsmedicine.symptombusinessSpleenSignal Transduction030215 immunologyScientific Reports
researchProduct

The modulation of immune complex aggregation by classical pathway-mediated reactions.

1985

Abstract Classical pathway (CP)-triggered reactions of complement-modulated immune complex(IC) aggregation (tetanus toxoid/human anti-tetanus toxoid-IgG; ICs of equivalence) were investigated turbidimetrically during the early stages of reaction. Monospecific Fab'- or Fab-fragments (rabbit) directed against certain complement components were used to block the complement function in normal human serum (NHS). Additionally, parts of the reactions were studied using purified complement components. C1q in serum generated by the addition of EDTA as well as purified C1q were found to increase the IC aggregation. In contrast to C1q, macromolecular C1 is able to inhibit IC aggregation, whereas addit…

EffectorChemistryComplement Activating EnzymesComplement C1qImmunologyToxoidHematologyAntigen-Antibody ComplexComplement System ProteinsComplement C1 Inactivator ProteinsImmune complexComplement componentsComplement (complexity)Classical complement pathwayBiochemistrySolubilityComplement C1ImmunologyImmunology and AllergyHumansComplement Pathway ClassicalComplement ActivationFunction (biology)MacromoleculeImmunobiology
researchProduct

The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.

1996

Virus-host interactions may have pathogenetic significance in chronic hepatitis. Thus the humoral immune response was evaluated during the clinical course of HCV-infected patients.Eighteen selected chronic HCV patients received three doses of 3 or 6 MU interferon-alpha 2a weekly for 6 to 12 months and were followed up for 6 to 60 months. Anti-HCV antibody levels were serially measured either in end-point diluted sera with the Matrix-Assay or with quantitative anti-HC34-IgG and -IgM ELISA. Circulating immune complexes were assessed by flow cytometry and the results were correlated with histology, quantitative HCV-RNA levels and genotypes.Nine complete responders (CR; genotypes 1a n = 4; 1b n…

AdultMaleGenotypeHepatitis C virusAlpha interferonEnzyme-Linked Immunosorbent AssayAntigen-Antibody ComplexHepacivirusBiologyInterferon alpha-2Immune complex formationmedicine.disease_causeVirusImmune systemInterferonmedicineHumansHepatologyInterferon-alphaHepatitis CHepatitis C AntibodiesMiddle Agedmedicine.diseaseFlow CytometryHepatitis CRecombinant ProteinsImmunologyAntibody Formationbiology.proteinFeasibility StudiesRNA ViralFemaleAntibodymedicine.drugJournal of hepatology
researchProduct